Saturday, September 16, 2017

Randomized withdrawal design and delayed start design in rare disease clinical trials

Last week at the 4th Duke-Industry Statistics Workshop, I participated in a session "Innovative clinical trial designs" organized by the UNC Professor, Dr Anastasia Ivanova.

I discussed 'randomized withdrawal design and delayed start design in rare disease clinical trials'. The presentation slides are included in the link below.


In rare disease clinical trials, we should think about more when designing the clinical trial and should

go beyond the typical, conventional RCT (randomized, controlled trials).

In the presentation, the following materials were referenced:

Randomized Withdrawal Design or Randomized Discontinuation Trial:

No comments: